Ahlcon Parenterals (India) Ltd. - Research Center
524448 AHLCONQ Group (B) BSE data
Results
Statement
More
Mar ' 15 |
Mar ' 14 |
Mar ' 13 |
Mar ' 12 |
Mar ' 11 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
82.62 |
66.34 |
46.88 |
34.10 |
30.00 |
Secured loans
0.02 |
2.92 |
9.60 |
18.66 |
25.14 |
Unsecured loans
Total
295.98 |
113.75 |
68.00 |
60.86 |
63.24 |
Gross block
323.07 |
89.72 |
82.98 |
83.21 |
80.58 |
Less : revaluation reserve
Less : accumulated depreciation
45.36 |
39.89 |
36.49 |
33.23 |
30.24 |
Net block
277.72 |
49.83 |
46.50 |
49.98 |
50.34 |
Capital work-in-progress
3.21 |
26.30 |
7.73 |
3.19 |
2.59 |
Investments
Current assets, loans & advances
57.54 |
66.42 |
40.48 |
29.92 |
28.66 |
Less : current liabilities & provisions
42.48 |
28.81 |
26.71 |
22.23 |
18.35 |
Total net current assets
15.05 |
37.61 |
13.77 |
7.69 |
10.31 |
Miscellaneous expenses not written
Total
295.98 |
113.75 |
68.00 |
60.86 |
63.24 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
14.93 |
141.10 |
7.37 |
16.42 |
6.78 |
Number of equity sharesoutstanding (Lacs)
72.00 |
72.00 |
72.00 |
72.00 |
72.00 |